Authors: Le Naour, F Misek, DE Krause, MC Deneux, L Giordano, TJ Scholl, S Hanash, SM

Citation: F. Le Naour et al., Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer, CLIN CANC R, 7(11), 2001, pp. 3328-3335

Authors: Tartour, E Mosseri, V Jouffroy, T Deneux, L Jaulerry, C Brunin, F Fridman, WH Rodriguez, J

Citation: E. Tartour et al., Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer, LANCET, 357(9264), 2001, pp. 1263-1264

Authors: Pichon, MF Basuyau, JP Gory-Delabaere, G Eche, N Daver, A Blanc-Vincent, MP Riedinger, JM Deneux, L Bidart, JM

Citation: Mf. Pichon et al., Standards, Options and Recommendations for tumor markers in thyroid cancers, B CANCER, 88(8), 2001, pp. 775-792

Authors: Scholl, SM Balloul, JM Le Goc, G Bizouarne, N Schatz, C Kieny, MP von Mensdorff-Pouilly, S Vincent-Salomon, A Deneux, L Tartour, E Fridman, W Pouillart, P Acres, B

Citation: Sm. Scholl et al., Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy inpatients with breast cancer, J IMMUNOTH, 23(5), 2000, pp. 570-580

Authors: Basuyau, JP Blanc-Vincent, MP Bidart, JM Daver, A Deneux, L Eche, N Gory-Delabaere, G Pichon, MF Riedinger, JM

Citation: Jp. Basuyau et al., Standards, Options and Recommendations (SOR) for tumor markers in breast cancer, B CANCER, 87(10), 2000, pp. 723-737